The company projects revenue between $1.05 billion and $1.09 billion for the coming fiscal year, exceeding the analyst consensus of $1.04 billion. This forward-looking confidence follows a strong fiscal fourth quarter, during which revenue grew 18% to $262 million.
In section Market Quotes
InnovAge Stock Surges on Strong Revenue Forecast
Shares of InnovAge climbed 11% to $11.67 in after-hours trading, fueled by a fiscal year revenue outlook that comfortably outpaced Wall Street expectations. The healthcare provider’s optimistic guidance arrives on the heels of a significant turnaround, with the company shifting from heavy losses to profitability in the most recent quarter.
Profitability metrics also signaled a sharp recovery. InnovAge reported a net income of $8.3 million, or 6 cents per share, marking a stark contrast to the $785,000 loss recorded during the same period last year. Having already doubled in value since the start of the year, the stock’s latest rally highlights investor reaction to the firm’s improved financial trajectory.
Comments (0)
No comments yet. Be the first!